These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review. Kamili QU; Miner A; Hapa A; Menter A J Drugs Dermatol; 2011 May; 10(5):539-44. PubMed ID: 21533302 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab. Chew AL; Bennett A; Smith CH; Barker J; Kirkham B Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561 [TBL] [Abstract][Full Text] [Related]
8. Response of severe psoriasis to infliximab. Mang R; Stege H; Ruzicka T; Krutmann J Dermatology; 2002; 204(2):156-7. PubMed ID: 11937748 [No Abstract] [Full Text] [Related]
9. Tumor necrosis factor (TNF) inhibitors revolutionalized therapy for both psoriasis and psoriatic arthritis. Foreword. Gottlieb AB Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S3-4. PubMed ID: 24777570 [No Abstract] [Full Text] [Related]
10. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699 [TBL] [Abstract][Full Text] [Related]
11. [Body-weight changes in psoriatic patients on systemic treatment]. Forien M; Mahé E; Sin C; Marchal A; Sigal ML Ann Dermatol Venereol; 2012 Oct; 139(10):649-51. PubMed ID: 23122380 [No Abstract] [Full Text] [Related]
12. A host of novel agents for treating psoriasis, psoriatic arthritis stir interest. Lamberg L JAMA; 2003 Jun; 289(21):2779-80, 2783. PubMed ID: 12783895 [No Abstract] [Full Text] [Related]
13. Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial. Reich K; Ortonne JP; Kerkmann U; Wang Y; Saurat JH; Papp K; Langley R; Griffiths CE Dermatology; 2010; 221(2):172-8. PubMed ID: 20628238 [TBL] [Abstract][Full Text] [Related]
14. Psoriatic rheumatism. Inflammatory arthropathy. Macovei L; Brujbu I Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):45-51. PubMed ID: 24741774 [TBL] [Abstract][Full Text] [Related]
15. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368 [TBL] [Abstract][Full Text] [Related]
16. Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre. Antoniou C; Stefanaki I; Stratigos A; Moustou E; Vergou T; Stavropoulos P; Avgerinou G; Rigopoulos D; Katsambas AD Br J Dermatol; 2010 May; 162(5):1117-23. PubMed ID: 19906069 [TBL] [Abstract][Full Text] [Related]
17. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349 [TBL] [Abstract][Full Text] [Related]
18. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment. Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426 [No Abstract] [Full Text] [Related]
19. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy of infliximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis. Fujisawa T; Moriya C; Shibuya Y; Kanoh H; Seishima M Acta Derm Venereol; 2013 May; 93(3):364-5. PubMed ID: 23007291 [No Abstract] [Full Text] [Related] [Next] [New Search]